跳至主要内容
临床试验/ISRCTN42493631
ISRCTN42493631已完成不适用

A Randomised Trial Comparing the Efficacy of Infusional 5-Fluorouracil (5-FU) to 5-FU plus Alpha Interferon in Patients with Unresectable Colorectal Cancer

The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histological evidence of metastatic adenocarcinoma of the colon or rectum not amenable to surgery or radiotherapy
  • 2. Patients evaluable for response must have bi-dimensionally measurable disease
  • 3. Patients with no measurable disease
  • 4. No prior treatment with 5-fluorouracil or other cyctotoxic agent or interferon
  • 5. Adequate bone marrow function
  • 6. Life expectancy of greater than 3 months
  • 7. Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • 8. No history of other malignant disease other than non melanotic skin cancer or carcinoma in situ of the cervix
  • 9. No intracerebral metastases or meningeal carcinomatosis
  • 10. No medical contraindications to treatment

排除标准

  • Not provided at time of registration

研究者

发起方
The Royal Marsden NHS Foundation Trust (UK)

相似试验